Quick Answer
Viridian Therapeutics, Inc.DE reported Total Assets of $899.42 million for fiscal year 2025.
Viridian Therapeutics, Inc.DE Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $899.42M | +21.1% |
| 2024 | $742.40M | +51.4% |
| 2023 | $490.42M | +12.7% |
| 2022 | $435.09M | +113.6% |
| 2021 | $203.71M | +55.2% |
| 2020 | $131.25M | +333.7% |
| 2019 | $30.26M | -54.3% |
| 2018 | $66.15M | +26.0% |
| 2017 | $52.48M | +112.0% |
| 2016 | $24.76M | +91.9% |
| 2015 | $12.90M | +59.5% |
| 2014 | $8.09M | +120.2% |
| 2013 | $3.67M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $577.14M | -25.2% | -0.9% |
| June 30, 2025 | $582.32M | -0.6% | -11.9% |
| March 31, 2025 | $660.98M | +4.9% | -11.0% |
| December 31, 2024 | $742.40M | +51.4% | -3.8% |
| September 30, 2024 | $771.90M | +134.8% | +31.8% |
| June 30, 2024 | $585.66M | +66.6% | -7.1% |
| March 31, 2024 | $630.38M | +63.0% | +28.5% |
| December 31, 2023 | $490.42M | +12.7% | +49.2% |
- Viridian Therapeutics, Inc.DE showed an increase of +21.1% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Viridian Therapeutics, Inc.DE’s total assets has grown by 24387.3% (from $3.67 million to $899.42 million).
- The most recent figure is from Viridian Therapeutics, Inc.DE’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: